Kiromic Biopharma, Inc. (KRBP) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 26 transactions totaling $105.5K, demonstrating a bullish sentiment with $105.5K in net insider flow. The most recent transaction on Aug 26, 2024 involved a purchase of 988 shares valued at $1.9K.
No significant insider buying has been recorded for KRBP in the recent period.
No significant insider selling has been recorded for KRBP in the recent period.
Based on recent SEC filings, insider sentiment for KRBP is bullish with an Insider Alignment Score of 100/100 and a net flow of $105.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Kiromic Biopharma, Inc. (KRBP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading KRBP stock, having executed 26 transactions in the past 90 days. The most active insider is Jerry A. Schneider (Executive), who has made 1 transactions totaling $36.5K.
Get notified when executives and directors at KRBP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Bersani Pietro | Executive | Purchase | 988 | $1.93 | $1.9K | |
| Aug 23, 2024 | Bersani Pietro | Executive | Purchase | 2,500 | $2.20 | $5.5K | |
| Aug 20, 2024 | Hungerford Brian | Executive | Purchase | 3,742 | $2.20 | $8.2K | |
| Aug 19, 2024 | Hungerford Brian | Executive | Purchase | 258 | $2.25 | $581 | |
| Aug 13, 2024 | Hungerford Brian | Executive | Purchase | 2,000 | $1.75 | $3.5K | |
| Jun 13, 2024 | Hungerford Brian | Executive | Purchase | 1,000 | $2.60 | $2.6K | |
| Jun 12, 2024 | Bersani Pietro | Executive | Purchase | 3,000 | $3.28 | $9.8K | |
| Jun 12, 2024 | Hungerford Brian | Executive | Purchase | 1,000 | $3.18 | $3.2K | |
| Jun 12, 2024 | Misajon Pamela | Executive | Purchase | 410 | $3.24 | $1.3K | |
| Jun 12, 2024 | Misajon Pamela | Executive | Purchase | 1,200 | $3.30 | $4.0K | |
| Jun 11, 2024 | Bersani Pietro | Executive | Purchase | 3,000 | $3.23 | $9.7K | |
| Jun 11, 2024 | Nagel Michael | Executive | Purchase | 1,000 | $3.33 | $3.3K | |
| Jun 10, 2024 | Misajon Pamela | Executive | Purchase | 1,701 | $2.93 | $5.0K | |
| May 3, 2024 | Bersani Pietro | Executive | Award | 45,968 | $N/A | $0 | |
| May 3, 2024 | Hungerford Brian | Executive | Award | 21,900 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 15 | $105.5K | 100.0% |
Award(A) | 9 | $0 | 0.0% |
Exercise(M) | 1 | $0 | 0.0% |
Other(J) | 1 | $0 | 0.0% |
Insiders at Kiromic Biopharma, Inc. are accumulating shares at an accelerated pace. With 10 insiders making 26 transactions totaling $105.5K in purchases versus $0 in sales, the net buying activity of $105.5K signals strong executive confidence. Jerry A. Schneider (Executive) leads the buying activity with $36.5K in transactions across all time.